These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7553955)
21. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma]. Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768 [TBL] [Abstract][Full Text] [Related]
22. Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells. Baral E; Nagy E; Krepart GV; Lotocki RJ; Unruh HW; Berczi I Anticancer Res; 2000; 20(3B):2027-31. PubMed ID: 10928146 [TBL] [Abstract][Full Text] [Related]
23. [Comparison of antitumor activity of tumor draining lymph node lymphocytes and peripheral blood lymphocytes in human oral cancer]. Guo W; Qiu WL; He RG Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Nov; 29(6):336-8, 384. PubMed ID: 7743875 [TBL] [Abstract][Full Text] [Related]
24. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters. Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270 [TBL] [Abstract][Full Text] [Related]
25. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
26. Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes. Kimoto Y; Taguchi T Biken J; 1987 Jun; 30(2):29-38. PubMed ID: 3501954 [TBL] [Abstract][Full Text] [Related]
27. Local adoptive immunotherapy using lymphokine-activated killer cells and interleukin-2 against malignant pleural mesothelioma: report of two cases. Yanagawa H; Sone S; Fukuta K; Nishioka Y; Ogura T Jpn J Clin Oncol; 1991 Oct; 21(5):377-83. PubMed ID: 1753419 [TBL] [Abstract][Full Text] [Related]
28. Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusions. Yanagawa H; Sone S; Nii A; Fukuta K; Nakanishi M; Maeda K; Honda M; Ogura T Jpn J Cancer Res; 1989 Dec; 80(12):1220-7. PubMed ID: 2516849 [TBL] [Abstract][Full Text] [Related]
29. Gamma-interferon enhances the cytotoxic activity of interleukin-2-induced peripheral blood lymphocyte (LAK) cells, tumor infiltrating lymphocytes (TIL), and effusion associated lymphocytes. Papamichail M; Baxevanis CN J Chemother; 1992 Dec; 4(6):387-93. PubMed ID: 1287141 [TBL] [Abstract][Full Text] [Related]
30. [Comparative study on cytotoxicity of lymphocytes from different tissues in laryngeal cancer]. An W Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(5):292-4, 314-5. PubMed ID: 8192933 [TBL] [Abstract][Full Text] [Related]
31. [In vitro induction of cytotoxic activity against carcinomatous pleural or peritoneal lymphoid cells cultivated with cytokines, and an immunological phenotypic analysis of the effector cells]. Ebihara T; Koyama S Gan No Rinsho; 1990 Apr; 36(5):604-10. PubMed ID: 2325266 [TBL] [Abstract][Full Text] [Related]
32. [Experimental studies on the antitumor activity of glioma-infiltrating lymphocytes against autologous glioma]. Li Y Zhonghua Yi Xue Za Zhi; 1992 May; 72(5):284-6, 319. PubMed ID: 1327462 [TBL] [Abstract][Full Text] [Related]
33. [In vitro experimental expansion and induction of LAK cell of lymphocytes from human carcinomatous ascites]. Li DJ Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):433-6. PubMed ID: 2634542 [TBL] [Abstract][Full Text] [Related]
34. [The characteristic of lymphokine-activated killer cells induced from tumor draining lymph-node cell]. Meng YG; Fu CY; Wang YZ Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):535-7, 574. PubMed ID: 7835130 [TBL] [Abstract][Full Text] [Related]
35. Induction of cytolytic activity of lymphocytes from carcinomatous pleural effusion by IL-2 and autologous tumor cells. Sairenji M; Yanoma S; Motohashi H; Kobayashi O; Okada K; Okamoto T; Tsukuda M; Umeda M Biotherapy; 1993; 6(4):283-90. PubMed ID: 8018449 [TBL] [Abstract][Full Text] [Related]
36. [In vitro induction of mature dendritic cells from malignant pleural effusions]. Huang H; Zeng BH; Chen JQ Ai Zheng; 2005 Jun; 24(6):663-6. PubMed ID: 15946474 [TBL] [Abstract][Full Text] [Related]
37. [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion]. Suzuki H Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1922-31. PubMed ID: 2608022 [TBL] [Abstract][Full Text] [Related]
38. X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions. Ishikawa E; Tsuboi K; Saijo K; Takano S; Ohno T Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1505-12. PubMed ID: 15275738 [TBL] [Abstract][Full Text] [Related]
39. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843 [TBL] [Abstract][Full Text] [Related]